Infantile Hemangioma
Conditions
Interventions
Group 1:Hemangioma Topical Drug
Group 2:Hemangioma Drug Patch
Sponsors
Shanghai Ninth People's Hospital
Eligibility
Sex/Gender
All
Age
No minimum to 0.5 Years
Inclusion criteria
Inclusion criteria: 1. Patients with untreated superficial infantile hemangioma in the proliferative stage; 2. Children younger than 6 months old; 3. Non-facial lesions; 4. The lesion area is less than 4cm^2, the height protruding from the skin surface is less than 3mm, and there is no ulcer, bleeding, infection, scar, etc. on the surface; 5. The family members of the children have informed and consented, and can cooperate with the inspection and follow-up required by the trial.
Exclusion criteria
Exclusion criteria: 1. Bronchial asthma, severe congenital heart disease; 2. The skin is allergic to ordinary tape; 3. Those who are participating in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analogue scale; | — |
Countries
China
Contacts
Public ContactLin Xiaoxi
Outcome results
None listed